| PLD2 |
PLD2: Phospholipase D2 |
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
10.060 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
PIK3CG |
PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i |
10.060 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
JAK1 |
|
10.060 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
TBK1 |
TBK1, NAK: Serine/threonine-protein kinase TBK1 |
10.060 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
PKN2 |
PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 |
10.060 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
MAPK12 |
MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 |
10.060 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
SYK |
SYK: Tyrosine-protein kinase SYK |
10.060 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
10.060 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
PAK4 |
PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 |
10.060 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
10.060 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
APS |
SH2B2, APS: SH2B adapter protein 2 |
10.060 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
RASA3 |
RASA3: Ras GTPase-activating protein 3 |
10.060 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
DUSP8 |
DUSP8, VH5: Dual specificity protein phosphatase 8 |
10.060 |
Evidence |
|
| CTTN |
CTTN, EMS1: Src substrate cortactin |
JAK1 |
|
10.040 |
Evidence |
|
| CTTN |
CTTN, EMS1: Src substrate cortactin |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
10.040 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
TUBB2A |
TUBB2A, TUBB2: Tubulin beta-2A chain |
10.040 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
SCML2 |
SCML2: Sex comb on midleg-like protein 2 |
10.040 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
CTTN |
CTTN, EMS1: Src substrate cortactin |
10.040 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
CXADR |
CXADR, CAR: Coxsackievirus and adenovirus receptor precursor |
10.040 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
10.040 |
Evidence |
|
| PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
10.040 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
10.020 |
Evidence |
O
|
| SF3A1 |
SF3A1, SAP114: Splicing factor 3 subunit 1 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
10.020 |
Evidence |
|
| PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
ACTN1 |
ACTN1: Alpha-actinin-1 |
10.010 |
Evidence |
|
| PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
WWC1 |
WWC1, KIAA0869: WW domain-containing protein 1 |
9.965 |
Evidence |
|